doi: 10.1002/dmrr.3070 Summary Keywords GLP-1 receptor agonists, thyroid disorders, thyroid cancer, meta-analysis, randomized controlled trials Citation Hu W, Song R, Cheng R, Liu C, Guo R, Tang W, Zhang J, Zhao Q, Li X and Liu J (2022) Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials
Health problems caused by overdoses of compounded semaglutide -- the main ingredient in Ozempic and Wegovy -- include severe nausea, vomiting and hypoglycemia, the FDA said
Therefore, drugs that stimulate GLP-1 receptors and inhibit GLP-1 breakdown, exenatide, and sitagliptin, respectively, reduce mices self-administration of nicotine
[17] The magnitude of improvement correlated with the amount of weight lost
J Endocrinol 2014;221:2937